Global Clinical Trials Market was valued at USD 42.6 billion in 2019 which is expected to reach USD 68.4 billion by 2030 at a CAGR 5.88%.
Clinical trials are the type of research study which is conducted on individuals for testing medical drugs or equipment to determine the treatment of certain disorders or diseases. Clinical trial has certain protocol and action plan to execute testing procedure. These are conducted to check the safety and efficacy of drug of any new medicine.
Increase in number of clinical trials and increase in demand for novel therapeutic drugs and medical devices which are expected to boost the global clinical trials market growth. Furthermore, increase in prevalence on chronic diseases like cancer, diabetes will have the positive impact on global clinical trials market growth. Moreover, COVID 19 pandemic is the global crisis overall the world to [prevent this crisis various clinical trials are in process which is expected to propel the growth of global clinical trials market growth. Also, increase in government initiatives and investments will fuel the global clinical trials market growth.
However, stringent rules and regulations is the restraining factor which is expected to hamper the global clinical trials market growth. Also, lack of qualified professionals will affect the global clinical trials market growth.
Global Clinical Trials Market is segmented into phase such as Phase I, Phase II, Phase III, and Phase IV, by design such as Interventional, Observation, and Expanded Access. Further, Global Clinical Trials Market is segmented into indication such as Cardiovascular, Obesity, Diabetes, CNS condition, Oncology, Pain management, Autoimmune/inflammation, and Others.
Also, Global Clinical Trials Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as ICON PLC, EUROTRIALS, ECRON ACUNOVA LTD, COVANCE INC. CONGENIX, CHILTERN INTERNATIONAL LIMITED, APTIV SOLUTIONS, ACCELL CLINICAL RESEARCH LLC, and AAIPHARMA SERVICES CORP.
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Clinical Trials Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Clinical Trials Market, By Phase
5.1 Y-o-Y Growth Comparison, By Phase
5.2 Global Clinical Trials Market Share Analysis, By Phase
5.3 Global Clinical Trials Market Size and Forecast, By Phase
5.3.1 Phase I
5.3.2Phase II
5.3.3 Phase III
5.3.4 Phase Iv
6 Global Clinical Trials Market, By Design
6.1 Y-o-Y Growth Comparison, By Design
6.2 Global Clinical Trials Market Share Analysis, By Design
6.3 Global Clinical Trials Market Size and Forecast, By Design
6.3.1 Interventional
6.3.2 Observational
6.3.3Expanded Access
7 Global Clinical Trials Market, By Indication
7.1 Y-o-Y Growth Comparison, By Indication
7.2 Global Clinical Trials Market Share Analysis, By Indication
7.3 Global Clinical Trials Market Size and Forecast, By Indication
7.3.1 Cardiovascular
7.3.2 Obesity
7.3.3 Diabetes
7.3.4CNS Condition
7.3.5Oncology
7.3.6Pain Management
7.3.7 Autoimmune/inflammation
7.3.8Others
8 Global Clinical Trials Market, By Region
8.1 Global Clinical Trials Market Share Analysis, By Region
8.2 Global Clinical Trials Market Share Analysis, By Region
8.3 Global Clinical Trials Market Size and Forecast, By Region
9 North America Clinical Trials Market Analysis and Forecast (2017 – 2030)
9.1 Introduction
9.2 North America Clinical Trials Market Share Analysis, By Phase
9.3 North America Clinical Trials Market Size and Forecast, By Design
9.4 North America Clinical Trials Market Size and Forecast, By Indication
9.5 North America Clinical Trials Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Clinical Trials Market Analysis and Forecast (2017 – 2030)
10.1 Introduction
10.2 Europe Clinical Trials Market Share Analysis, By Phase
10.3 Europe Clinical Trials Market Size and Forecast, By Design
10.4 Europe Clinical Trials Market Size and Forecast, By Indication
10.5 Europe Clinical Trials Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Clinical Trials Market Analysis and Forecast (2017 – 2030)
11.1 Introduction
11.2 Asia Pacific Clinical Trials Market Share Analysis, By Phase
11.3 Asia Pacific Clinical Trials Market Size and Forecast, By Design
11.4 Asia Pacific Clinical Trials Market Size and Forecast, By Indication
11.5 Asia Pacific Clinical Trials Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Clinical Trials Market Analysis and Forecast (2017 – 2030)
12.1 Introduction
12.2 Latin America Clinical Trials Market Share Analysis, By Phase
12.3 Latin America Clinical Trials Market Size and Forecast, By Design
12.4 Latin America Clinical Trials Market Size and Forecast, By Indication
12.5 Latin America Clinical Trials Market Size and Forecast, Country
13 Middle East Clinical Trials Market Analysis and Forecast (2017 – 2030)
13.1 Introduction
13.2 Middle East Clinical Trials Market Share Analysis, By Phase
13.3 Middle East Clinical Trials Market Size and Forecast, By Design
13.4 Middle East Clinical Trials Market Size and Forecast, By Indication
13.5 Middle East Clinical Trials Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Icon Plc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Eurotrials
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Acunova Ltd
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Covance Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Congenix
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Chiltern International Limited
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Aptiv Solutions
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Accell Clinical Research Llc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Aaipharma Services Corp
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
